Open Access<p>Low Concentrations of Dehydroepiandrosterone Sulfate are Associated with Depression and Fatigue in Patients with Non-Small-Cell Lung Cancer After Chemotherapy</p>
Author(s) -
Fang Yu,
MengJer Hsieh,
Ming Szu Hung,
Yu Ching Lin,
LiangTseng Kuo,
Mong Liang Lu,
BorShow Tzang,
Vincent Chin Hung Chen
Publication year - 2020
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s265182
Subject(s) - medicine , lung cancer , dehydroepiandrosterone sulfate , chemotherapy , depression (economics) , oncology , endocrinology , hormone , androgen , economics , macroeconomics
Dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) concentrations were reported to decrease in patients with advanced cancer. However, the clinical significance of DHEA and DHEAS concentrations in patients with NSCLC receiving chemotherapy (CT) has not been sufficiently documented.